Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.

The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That’s because a ...

Tirzepatide is approved by the Food and Drug ... Novo Nordisk and Eli Lily. So prescribing these purportedly “custom” compounded injections is “a practice that is worrisome, and it’s ...

Despite instructions of closure by federal authorities tomorrow, many compounded versions of weight-loss drugs are available ...

More recently, pop star Lady Gaga and actresses Lily Collins are among the many ... the company that sells Zepbound – a brand name for Tirzepatide, a medication similar to Ozempic – took ...

You can also even look at 5 mg of tirzepatide and SURMOUNT-1 there ... seconds just to spend a moment as to why you view those or Lily views those as game changing events? Jacob Van Naarden ...

As it stands, pharmacies and outsourcing facilities are required to wind down production of tirzepatide by 18th February and 19th March, respectively. Lilly has also argued that the presence of ...

Semaglutide is the active ingredient of Novo Nordisk’s (NOV: N) diabetes drug Ozempic and weight management brand Wegovy, whereas tirzepatide is likewise for Eli Lily’s (NYSE: LLY) for diabetes drug ...

A United States Senator has disclosed a series of stock trades, some raising questions about possible insider information use ...